Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

1 729 evidences · page 12 / 70

72,1 %Of the 2,739 PLHIV 15 years and above identified in NAIIS, 1,975 (72.1%) were either unaware of their HIV-positive status or were aware but not receiving treatment.

NigeriaVIH/sidaobservé 2018publié 2021PloS onePubMeddocument de 13 observations

50 %The prevalence of refractive errors among persons living with HIV/AIDS in Osun State, Nigeria was 50.0%.

Nigeriarefractive errors · VIH/sidapublié 2026BMC ophthalmologyPubMeddocument de 9 observations

99,2 %Among 800 enrolled sexual and gender minorities living with HIV in Nigeria, 99.2% were on antiretroviral therapy.

NigeriaVIH/sidapublié 2023Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 5 observations

14 %HIV seroprevalence in Nigeria among men who have sex with men increased from 14% in 2007 to 23% in 2014.

NigeriaVIH/sidaobservé 2007publié 2023AIDS research and therapyPubMed

75,7 %Knowledge of male partners' HIV status was 75.7% among expert mothers versus 66.7% among non-expert mothers.

NigeriaVIH/sidapublié 2020PloS onePubMeddocument de 7 observations

23,9 %HSV-2 prevalence among sexual and gender minorities without HIV-1 in Lagos, Nigeria was 23.9%.

NigeriaHerpes simplex virus type 2 · VIH/sidapublié 2023AIDS research and human retrovirusesPubMeddocument de 3 observations

10,9 %The lowest proportion of downward misclassification for V-DBS was 10.9% at the 1000 copies/mL threshold.

NigeriaVIH/sidapublié 2021Journal of clinical virology : the official publication of the Pan American Society for ClPubMeddocument de 5 observations

23 %Twenty-three percent of the 1442 HIV-1 pol sequences represented unique recombinant forms (URFs).

NigeriaVIH/sidaobservé 1999-2014publié 2020Scientific reportsPubMeddocument de 6 observations

49,6 %Of 1745 tested participants, 865 (49.6%) were living with HIV in the TRUST/RV368 cohort in Nigeria.

NigeriaVIH/sidapublié 2020Journal of the International AIDS SocietyPubMeddocument de 8 observations

54 %About 54% of adults adhered to antiretroviral therapy.

NigeriaVIH/sidapublié 2023African health sciencesPubMeddocument de 3 observations

22 %Compared to pre-fee patients, the post-fee period had a 22% decreased risk of loss to follow-up (aRR = 0.64, 95%CI:0.96).

NigeriaVIH/sidapublié 2020PloS onePubMeddocument de 9 observations

2,57 %Among HIV-positive patients aged 31–40 years in the study, the prevalence of HIV/HCV co-infection was 2.57%.

Nigeriahépatite C · VIH/sidaobservé 2019publié 2020Journal of immunoassay & immunochemistryPubMeddocument de 9 observations

There was a significant positive correlation between CD4 counts and eosinophil count among HIV-1 individuals.

NigeriaVIH/sidapublié 2020Journal of immunoassay & immunochemistryPubMeddocument de 15 observations

6 926 patientsAmong patients enrolled on antiretroviral therapy from 2004 to 2017, 6,926 (2.8%) died.

NigeriaVIH/sidaobservé 2004 to 2017publié 2019AIDS research and therapyPubMeddocument de 11 observations

6,3 %Minor PI resistance-associated mutation L33F was identified in 6.3% of CRF02_AG HIV-1 isolates.

NigeriaVIH/sidapublié 2020PloS onePubMeddocument de 11 observations

2,3 %Between July 2016 and October 2017, 2.3% of male participants at Baby Shower events in Benue State, Nigeria received new HIV-positive diagnoses.

NigeriaVIH/sidaobservé July 2016 to October 2017publié 2021PloS onePubMeddocument de 11 observations

17 %Only 17% of the treatment cards had isoniazid prescribed.

NigeriaVIH/sidapublié 2022Malawi medical journal : the journal of Medical Association of MalawiPubMeddocument de 4 observations

130 000 peopleIn Nigeria, 130,000 people were newly infected with HIV.

NigeriaVIH/sidapublié 2022The Pan African medical journalPubMeddocument de 6 observations

3,96 odds_ratioThe odds of macroalbuminuria were higher for participants with the APOL1 high-risk genotype compared to those carrying the low-risk genotype (adjusted odds ratio 3.96, 95% confidence interval 1.95–8.02).

NigeriaVIH/sidapublié 2021Kidney internationalPubMeddocument de 7 observations

90 %Among 10 HBV DNA-positive samples with drug resistance mutations, 90.0% (9/10) were from ART-experienced individuals.

NigeriaVIH/sidaobservé June 2017 to August 2017publié 2021Virology journalPubMeddocument de 6 observations

40,9 %The proportion of HIV-positive male partners with adequate PMTCT knowledge was 40.9%.

NigeriaVIH/sidapublié 2020Current HIV researchPubMeddocument de 5 observations

80,3 %Among 300 participants, 241 (80.3%) had voluntarily disclosed their HIV status to someone within their social network.

NigeriaVIH/sidaobservé March to August 2019publié 2021Indian journal of public healthPubMeddocument de 3 observations

98,6 %Overall retention to care was 98.6%.

NigeriaVIH/sidaobservé May 2022 to May 2023publié 2026BMC public healthPubMeddocument de 9 observations

268 cells_per_mm3The mean CD4 count at enrollment in care was 268 ± 23.7 cells per mm³.

NigeriaVIH/sidapublié 2020AIDS research and therapyPubMeddocument de 12 observations

3,37 aorSpousal HIV-positive status was associated with improved HRQOL (adjusted odds ratio = 3.37, 95% confidence interval: 1.46–7.74).

NigeriaVIH/sidapublié 2020BMC public healthPubMeddocument de 11 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.